Genis: Funding, Investors & Team (Oct 2026)
Genis is a biotechnology company headquartered in Siglufjörður, Iceland. We strive to discover, develop and commercialize novel and life changing pharmaceutical products, supplements and medical devices derived from crustacean exoskeletons. The Genis team has been developing cutting edge research on the production of chitin, chitosan and chitin derived oligosaccharides for two decades. Our mission is to leverage this accumulated body of world class scientific research with the intent of providing life altering benefits for individuals suffering from a broad spectrum of inflammatory and degenerative conditions.
Genis has raised $17.0M across 1 funding round on record, the most recent an undisclosed round of $17.0M announced in Dec 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genis Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Genis Funding Rounds
Genis Founders and Leadership Team
No contact details are on record for this team yet.
Genis Funding Compared to Other Biotechnology Startups
Genis' latest round of $17.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genis in Biotechnology and Siglufjörður
Companies Similar to Genis
The Oculis platform for drug delivery is a new method that aids the absorption of drugs to both the front and…
Alvotech is a global biopharmaceutical company, focused on developing biosimilar versions of leading…
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Genis Funding FAQs
What does Genis do?
Genis is a biotechnology company headquartered in Siglufjörður, Iceland. We strive to discover, develop and commercialize novel and life changing pharmaceutical products, supplements and medical devices derived from crustacean exoskeletons. The Genis team has been developing cutting edge research on the production of chitin, chitosan and chitin derived oligosaccharides for two decades. Our mission is to leverage this accumulated body of world class scientific research with the intent of providing life altering benefits for individuals suffering from a broad spectrum of inflammatory and degenerative conditions.
How much funding has Genis raised?
Genis has raised $17.0M across 1 round on record. The most recent is an undisclosed round of $17.0M announced in Dec 2022.
When did Genis last raise funding?
Genis' most recent funding round on record is an undisclosed round of $17.0M, announced in Dec 2022.
Who founded Genis?
FundedIQ lists Junyong Lee (Founder) at Genis.
Where is Genis headquartered?
Genis is based in Siglufjörður, Eyjafjardarsysla, Iceland.
How many employees does Genis have?
Genis is in the 51-100 employee band.
How does Genis' funding compare to other Biotechnology startups?
Genis' latest round of $17.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Genis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.